Molecular Determinants of Crosstalk between Nuclear Receptors and Toll-like Receptors  by Ogawa, Sumito et al.
Cell, Vol. 122, 707–721, September 9, 2005, Copyright ©2005 by Elsevier Inc. DOI 10.1016/j.cell.2005.06.029
Molecular Determinants of Crosstalk
between Nuclear Receptors and Toll-like ReceptorsSumito Ogawa,1 Jean Lozach,1 Chris Benner,1,2
Gabriel Pascual,1 Rajendra K. Tangirala,4,7
Stefan Westin,4 Alexander Hoffmann,5
Shankar Subramaniam,2 Michael David,3
Michael G. Rosenfeld,6 and Christopher K. Glass1,6,*
1Department of Cellular and Molecular Medicine
2Department of Bioengineering
3Department of Biology
University of California, San Diego
9500 Gilman Drive
La Jolla, California 92093
4Exelixis, Inc.
San Diego, California 92121
5Department of Chemistry and Biochemistry
6Department of Medicine
Howard Hughes Medical Institute
University of California, San Diego
9500 Gilman Drive
La Jolla, California 92093
Summary
Nuclear receptors (NRs) repress transcriptional re-
sponses to diverse signaling pathways as an essential
aspect of their biological activities, but mechanisms
determining the specificity and functional conse-
quences of transrepression remain poorly understood.
Here, we report signal- and gene-specific repression
of transcriptional responses initiated by engagement
of toll-like receptors (TLR) 3, 4, and 9 in macrophages.
The glucocorticoid receptor (GR) represses a large
set of functionally related inflammatory response
genes by disrupting p65/interferon regulatory factor
(IRF) complexes required for TLR4- or TLR9-depen-
dent, but not TLR3-dependent, transcriptional activa-
tion. This mechanism requires signaling through
MyD88 and enables the GR to differentially regulate
pathogen-specific programs of gene expression.
PPAR and LXRs repress overlapping transcriptional
targets by p65/IRF3-independent mechanisms and
cooperate with the GR to synergistically transrepress
distinct subsets of TLR-responsive genes. These
findings reveal combinatorial control of homeostasis
and immune responses by nuclear receptors and
suggest new approaches for treatment of inflamma-
tory diseases.
Introduction
Members of the nuclear receptor superfamily play di-
verse roles in the regulation of development, homeo-
stasis, and immune responses by both positively and
negatively regulating gene expression. The glucocorti-*Correspondence: cglass@ucsd.edu
7 Present address: Division of Endocrinology, Diabetes and Hyper-
tension, David Geffen School of Medicine, University of California,
Los Angeles, Los Angeles California, 90095.coid receptor (GR) is prototypic of a subset of ligand-
dependent nuclear receptors that integrate host im-
mune responses with physiological circuits that are re-
quired for maintenance of necessary organ functions.
The ability of GR to repress transcriptional responses
to inflammatory signals is an essential component of
its homeostatic functions and a primary mechanism by
which natural and synthetic GR agonists exert anti-
inflammatory effects in a variety of disease settings
(Reichardt et al., 2001, and reviewed in De Bosscher et
al. [2003]). Negative regulation of inflammatory re-
sponses is thought to result, at least in part, from the
ability of GR to interfere, by transrepression, with the
activities of other signal-dependent transcription fac-
tors that include NF-κB and activator protein-1 (AP-1)
family members (Jonat et al., 1990; Ray and Prefon-
taine, 1994; Schüle et al., 1990). Numerous models
have been proposed for GR-mediated transrepression,
including direct interactions with NF-κB components
(Caldenhoven et al., 1995; Liden et al., 1997; Schein-
man et al., 1995b), regulation of components of signal-
transduction pathways involved in NF-κB and AP-1 ac-
tivation (Auphan et al., 1995; Caelles et al., 1997;
Scheinman et al., 1995a), competition for essential co-
activators (Kamei et al., 1996; Sheppard et al., 1998),
alternative utilization of coactivators (Kassel et al.,
2004; Rogatsky et al., 2001; Scheinman et al., 1995b),
recruitment of corepressors (Nissen and Yamamoto,
2000), and modifications of core transcription factors
(De Bosscher et al., 2000; Nissen and Yamamoto, 2000).
However, most of these models have been developed
based on analysis of limited sets of specific target genes
and general applicability to broad programs of gene ex-
pression activated during inflammatory responses have
not been established.
Anti-inflammatory activities have also been docu-
mented in vivo and/or in vitro for several other mem-
bers of the nuclear-receptor family, including estrogen
receptors (ERs) (McKay and Cidlowski, 1999), vitamin
D receptors (VDRs) (Nagpal et al., 2001), peroxisome
proliferator-activated receptors (PPARs) (Devchand et
al., 1996; Jiang et al., 1998; Ricote et al., 1998), and
LXRs (Castrillo and Tontonoz, 2004). PPARs and LXRs
are regulated by fatty acid and cholesterol metabolites,
respectively, and were initially characterized as nuclear
receptors that play critical roles in lipid homeostasis
(Issemann and Green, 1990; Janowski et al., 1996).
Emerging evidence suggests that their ability to
counterregulate inflammatory responses plays impor-
tant roles in both immunity and metabolic control
(Castrillo and Tontonoz, 2004; Joseph et al., 2004;
Valledor et al., 2004).
Here, we have used toll-like receptor (TLR) signaling
as a model system to explore mechanisms by which
different members of the nuclear-receptor superfamily
repress proinflammatory programs of gene expression.
GR, PPARγ, and LXR agonists were found to repress
both common and distinct subsets of TLR target genes
through the use of nuclear-receptor- and TLR-specific
transrepression mechanisms. Combinations of ago-
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708nists for GR, PPARγ, and LXRs resulted in additive or
synergistic inhibition of a subset of TLR4-target genes
both in cultured macrophages and in vivo, consistent
with the simultaneous targeting of these genes by dis-
tinct mechanisms. These findings suggest that nuclear
receptors function in a combinatorial manner to coordi-
nately regulate the evolution of host immune re-
sponses.
Results
Nuclear Receptors Inhibit Overlapping but Distinct
Subsets of LPS-Inducible Genes
Gene-expression profiling experiments were initially
performed to identify LPS-inducible genes in primary
macrophages that were sensitive to transrepression by
the GR agonist dexamethasone (Dex; Figure 1A). The
observation that about half of the LPS-inducible genes
were Dex-sensitive raised the questions of how GR
discriminated between sensitive and resistant genes
and whether these two classes of genes exert distinct
biological functions. Recent findings indicate that
NCoR corepressor complexes occupy a subset of NF-
κB and AP-1 target genes under basal conditions and
are cleared in a signal-dependent manner as a prereq-
uisite to transcriptional activation (Ogawa et al., 2004;
Perissi et al., 2004). Because some NCoR target genes
were also subject to Dex-mediated repression, microar-
ray experiments were performed using NCoR−/− macro-
phages to determine whether NCoR was required for
Dex sensitivity (Ogawa et al., 2004). Lack of NCoR had
no impact on GR-mediated repression (Figure 1B), indi-
cating the utilization of NCoR-independent mecha-
nisms. To investigate whether different nuclear recep-
tors repress a common set of LPS target genes, gene
expression profiling experiments were performed using
nuclear-receptor-specific agonists for PPARγ (rosiglita-
zone [Ro] and GW7845), LXRα/β (GW3965 and T1317),
VDR (1,25-(OH)2vitamin D3), ER (17β-estradiol; E2), and
RARs (all-trans retinoic acid; atRA). These experiments
demonstrated that each agonist exerted an overlapping
but distinct impact on LPS-dependent gene expression
(Figures 1C and 1D). GR, LXR, and PPARγ agonists
were the most potent inhibitors of the LPS response,
with VDR-, ER-, and RAR-specific agonists exerting rel-
atively modest inhibitory effects under these conditions
(Figure 1C). Sensitivity to repressive effects of GR,
PPARγ, or LXR agonists did not correlate with degree
of responsiveness to LPS (Figure 1C), absolute expres-
sion levels, or a requirement for the p65 component of
NF-κB (data not shown and see Figure S1 in the Sup-
plemental Data available with this article online).
p65/IRF3 Complexes Mediate Signal-Specific
Inhibition of Transcriptional Responses
Computational motif discovery methods were used to
search for potential transcriptional regulatory elements
mediating LPS-dependent activation and nuclear-recep-
tor-mediated transrepression. The sequence cAAAct
GAAAg was identified as the most highly significant
motif enriched in the promoter sequences of LPS target
genes (Figure 2A). This motif is nearly identical to con-
sensus IRF3 and interferon (IFN)-sensitive response el-
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iment (ISRE) sequences recognized by IRF3 and the
ype I IFN-inducible ISGF3 complex. Binding of poly I:C
o TLR3 and LPS to TLR4, respectively, activates IRF3
nd induces ISRE-mediated gene activation (Pitha,
004; Servant et al., 2002). We therefore performed ex-
ression-profiling experiments to compare the impact
f GR, PPARγ, and LXR agonists on transcriptional re-
ponses of macrophages to TLR3 and TLR activation
Figure 2C). TLR4 signals through both Myd88-depen-
ent and TRIF-dependent pathways, while TLR3 exclu-
ively signals through the TRIF-dependent pathway
Akira and Takeda, 2004; Pitha, 2004). Despite this dif-
erence, the qualitative and quantitative pattern of
enes induced more than 3-fold by LPS and poly I:C at
he 6 hr time point were very similar (Figure 2B). In par-
llel, gene expression profiling experiments were per-
ormed to identify IRF3-target genes by comparing LPS
esponses of wild-type and IRF3−/− macrophages (Sato
t al., 2000; Figure 2C; Table S1).
As in the case of LPS-dependent gene expression,
R, PPARγ, and LXR agonists repressed both common
nd nuclear-receptor-specific targets of poly I:C-induc-
ble genes (Figure 2C). However, despite the overall
imilarity in the sets of genes that were transcriptionally
ctivated by LPS and poly I:C, the patterns of GR-,
PARγ-, and LXR-mediated transrepression were sig-
ificantly different, indicating that nuclear-receptor
ransrepression is regulated in a signal-specific man-
er. In particular, a substantial number of genes that
ere Dex sensitive when activated by LPS became
ex-resistant when activated by poly I:C, illustrated for
P10 and Ifit1 in Figure 2D.
Unexpectedly, nearly all of the highly inducible LPS-
nd poly I:C target genes that were Dex sensitive when
ctivated by LPS but Dex resistant when activated by
oly I:C were also highly dependent on IRF3 for LPS
nduction (Figure 3A and data not shown). The promot-
rs for many of the genes exhibiting this pattern of ex-
ression contained proximal IRF3/ISRE sequences,
xemplified by Ifit1 (Figure 3B). In contrast, while
PARγ and LXR agonists also inhibited a significant
umber of IRF3-dependent genes, the signal-specific
attern of sensitivity and resistance differed (Figures
C and 3A). This pattern therefore suggested a mecha-
istic link between IRF3 and signal-specific transre-
ression by GR. To test this hypothesis, we evaluated
he ability of GR to repress transcriptional activation of
n artificial promoter constructed to exclusively contain
SRE elements, which was activated by LPS and poly
:C (Figure 3C). Significantly, the induction of the ISRE-
ependent reporter was strongly inhibited by Dex when
PS was used as a stimulus, but not when poly I:C was
sed as a stimulus (Figure 3C).
While TLR3 and TLR4 signaling both lead to activa-
ion of IRF3, recent studies suggest that p65/RelA func-
ions as an essential coactivator of IRF3 in the case of
LR4 signaling, but not in case of TLR3 signaling (Wie-
ek et al., 2003). The p65 requirement for LPS induction
f an ISRE-dependent gene was confirmed by experi-
ents demonstrating markedly impaired activation of
he Ifit1 gene in NF-κB-deficient macrophages (Figure
D). These observations raised the possibility that GR
nhibited IRF3-target genes in response to TLR4 signal-
ng, but not TLR3 signaling, by targeting the p65 require-
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709Figure 1. Inhibition of LPS-Dependent Gene Expression by Nuclear-Receptor Agonists
(A) Relative expression of LPS-inducible genes in peritoneal macrophages under control conditions and after 6 hr of LPS treatment in the
absence or presence of 1 M Dex. Left panel, genes induced by LPS >2-fold. Middle panel, genes induced by LPS >2-fold and inhibited by
Dex more than 50% (Dex-sensitive). Right panel, genes induced by LPS >2-fold and resistant to Dex.
(B) Dex-mediated transrepression of LPS-inducible genes in macrophages derived from fetal liver-derived macrophages of wild-type (WT)
and NCoR−/− mice. The illustrated gene expression values are for the 12 most highly repressed genes in wild-type macrophages.
(C) Effect of nuclear-receptor agonists on responsiveness of 208 LPS target genes in peritoneal macrophages. Genes are ordered based on
magnitude of average LPS induction over 4 experiments from >40-fold at the top to 2-fold at the bottom. Genes in which the LPS response
was not altered by agonist treatment are illustrated in gray. Red indicates ligand-dependent upregulation and blue ligand-dependent downreg-
ulation of the LPS response. The magnitude of the effect is indicated by the key at lower left.
(D) Confirmation of negative regulation of LPS target genes by Northern blotting. Macrophages were treated with LPS for 6 hr in the presence
of 1 M concentrations of the indicated agonists.
Cell
710Figure 2. Differential Repression of TLR Responses by GR, PPARγ, and LXRs
(A) Identification of IRF3 binding sites as highly enriched sequence motifs in the promoters of LPS-inducible genes. The top sequence logo
is representative of the most significant motif present in the promoters of genes that are LPS-inducible and not present in promoters of non-
LPS-inducible genes.
(B) A scatter plot illustrating fold responses to poly I:C compared to genes activated at least 3-fold by LPS.
(C) Effect of IRF3 deficiency and GR (Dex), LXR (GW3965), or PPARγ (GW7845) agonists on transcriptional responses to LPS and poly I:C.
The panel illustrates the 208 most highly induced LPS-responsive genes. Sensitivity of each gene to loss of IRF3 (column 1) or treatment with
Dex, GW3965, and GW7845 is color coded as indicated in the key at the bottom.
(D) Confirmation of signal-specific repression of LPS- and poly I:C-inducible genes by GR-, LXR-, and PPARγ-specific agonists. Macrophages
were treated with LPS or poly I:C for 6 hr in the presence of 1 M concentrations of the indicated agonists.ment. We therefore characterized the composition of acti-
vation complexes bound to the proximal promoter region
of Ifit1 in primary macrophages by chromatin immuno-
precipitation (ChIP) assay. These experiments demon-
strated that IRF3 and CBP were prominently recruited
to the ISRE-containing promoter in response to both LPS
a
a
r
p
i
3nd poly I:C (Figure 3E). In contrast, p65 was specific-
lly recruited to the ISRE in response to LPS, but not in
esponse to poly I:C. Interestingly, the recruitment of
65 to the ISRE in response to LPS was largely inhib-
ted by Dex, but not by PPARγ or LXR agonists (Figure
E). Similar findings were obtained using ChIP to evalu-
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711ate the composition of activation complexes bound to
the artificial promoter construct exclusively containing
ISRE elements (Figure S2).
Previous studies have suggested that nuclear-recep-
tor interactions with p65 are involved in transrepression
(Liden et al., 1997; Scheinman et al., 1995b), but how
this interaction could account for receptor-, signal-,
and gene-specific repression has not been established.
We therefore evaluated the possibility that GR inhibitedFigure 3. Signal-Specific Repression by GR Correlates with a Requirement for IRF3 for Transcriptional Activation
(A) Transcriptional responses of 54 genes highly induced by LPS, poly I:C, and CpG1668, exhibiting sensitivity to Dex when activated by LPS
(column 2) and resistance to Dex when activated by poly I:C (column 3). The dependence of the LPS response on IRF3 is indicated in the
first column. Effects of IRF3 deficiency or nuclear-receptor agonists are color coded as in Figure 2C.
(B) Promoter structure and expression profile of Ifit1 in response to LPS, poly I:C, and Dex in wild-type (WT) and IRF3−/− peritoneal macro-
phages. Error bars represent standard deviations.
(C) An ISRE-specific promoter exhibits LPS-specific repression by Dex. U373 cells were transfected with a 5× ISRE-Luc reporter plasmid.
Cells were treated with the indicated combinations of LPS (100 ng/ml), poly I:C (50 g/ml), and Dex and analyzed for luciferase activity 18 hr
later. Error bars represent standard deviations.
(D) Expression of Ifit1 in response to LPS (1 g/ml) in control and NF-κB−/− fetal liver-derived macrophages.
(E) p65 recruitment to the proximal promoter region of Ifit1 is specifically induced by LPS and inhibited by activation of GR. Primary macro-
phages were treated with LPS (100 ng/ml), poly I:C (50 g/ml), and the indicated agonists for GR, PPARγ and LXRs for 1 hr. ChIP assays were
performed with antibodies against IRF3, CBP, p65 and control IgG, respectively. Immunoprecipitated DNA was analyzed by PCR using primers
specific for the promoter.LPS induction of the ISRE promoter through direct in-
teractions with p65. In vitro interaction assays con-
firmed that the GR-DBD strongly interacted with both
full-length p65 and further narrowed this interaction to
the N-terminal Rel-homology domain (RHD; Figure 4A).
In contrast, the PPARγ-DBD and the LXRα-DBD exhib-
ited minimal interaction with p65 in vitro (Figure 4A).
These results were confirmed by mammalian two-
hybrid assays using a Gal4DBD-p65 fusion protein as
Cell
712Figure 4. GR Specifically Inhibits the Interac-
tion of p65 with IRF3
(A) GR-DBD preferentially interacts with the
p65 RHD. GST pull-down assays were per-
formed using the indicated GST-NR-DBD fu-
sion proteins and in vitro translated full-
length p65 or p65 RHD, respectively.
(B) Wild-type GR preferentially interacts with
p65 in vivo in a ligand-dependent manner.
The mammalian two-hybrid assay was per-
formed in RAW264.7 cells using Gal-p65 as
bait and the indicated VP16 nuclear-receptor
fusion proteins as preys in the presence and
absence of agonists. Error bars represent
standard deviations.
(C) GR-DBD inhibits interaction of IRF3 with
p65. GST pull-down assays were performed
using GST-p65 and increasing amounts of in
vitro translated full-length IRF3 and/or GR-
DBD as indicated.
(D) IRF3 interacts with the p65 RHD in vitro.
GST pull-down assays were performed using
GST-p65 RHD and in vitro translated full-
length IRF3.
(E) GR-DBD mutant GRK471A is unable to in-
teract with the p65 RHD in vitro. GST pull-
down assays were performed using GST-p65
RHD and in vitro translated full-length GR
and GRK477A, respectively.
(F) Inhibition of Gal-p65 transactivation by li-
ganded wild-type GR but not by GRK477A.
Endogenous GR expression in mouse
RAW264.7 cells was knocked down by pre-
treatment with a GR-specific siRNA for 48 hr.
Cells were then transfected with expression
vectors for Gal4 (Gal), Gal4-p65 (Gal-p65),
wild-type human GR or GRK477A as indicated
in the presence of Dex. Error bars represent
standard deviations.
(G) Coactivation of Gal-IRF3 by p65 is inhib-
ited by liganded wild-type GR but not by
GRK477A. Endogenous GR expression in
RAW264.7 cells was knocked down by pre-
treatment with a GR-specific siRNA for 48 hr
prior to transfection with expression vectors
for human wild-type GR or GRK477A and
treatment with Dex as indicated. Error bars
represent standard deviations.bait and VP16 fusions with full-length GR, PPARγ, or
LXRα as preys (Figure 4B). In vitro binding assays dem-
onstrated that a glutathione-S-transferase (GST)-p65
fusion protein also interacted with IRF3 through the
RHD (Figures 4C and 4D). Addition of increasing
amounts of GR-DBD to the binding reaction led to de-
creased IRF3 interaction with p65 and a concomitant
increase in the binding of the GR-DBD (Figure 4C).
These findings suggest that GR and IRF3 compete for
the same binding site and that GR preferentially in-
teracts with p65.
To determine whether the interaction of GR with p65
was relevant to its repression function, we evaluated a
GR mutant in which lysine 471 in the second zinc finger
of the DBD was changed to alanine (GRK471A) based on
a previous report that a corresponding mutant is de-
fective for inhibition of p65 activity (Liden et al., 1997).
In contrast to wild-type GR, GRK471A exhibited little in-
teraction with p65 in vitro or in vivo in mammalian two-
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iybrid assays (Figures 4B and 4E), and GRK471A lacked
nhibitory activity against Gal-p65-mediated transacti-
ation (Figure 4F). Consistent with these in vitro find-
ngs, wild-type GR was able to inhibit p65-dependent
ransactivation of a Gal-IRF3 fusion gene, while
RK471A was not (Figure 4G), suggesting that direct in-
eraction of GR and p65 is required for GR-mediated
ransrepression of IRF3. Taken together, these findings
upport a model in which the requirement of ISRE-con-
aining genes for p65 as a coactivator following LPS
ctivation, but not poly I:C stimulation, accounts for the
PS-specific sensitivity of these genes to transrepres-
ion by GR.
RF3/p65 Complexes Mediate Gene-Specific
nhibition of Transcriptional Responses
n addition to the IRF3 binding motif, κB elements were
lso highly enriched in promoter regions of LPS-induc-
ble genes (Table S1). However, the presence of these
Crosstalk between Nuclear Receptors and TLRs
713Figure 5. Utilization of IRF3 as a Coactivator of p65 Determines Gene-Specific Sensitivity
(A) Location of NF-κB sites in proximal promoter regions of Scyb9, Clic4, Nfkbia, and Gro1, and their expression profiles in response to LPS
in wild-type (WT) and IRF3−/− peritoneal macrophages. Error bars represent standard deviations.
(B) Expression profiles of Scyb9, Clic4, Nfkbia, and Gro1 in response to LPS and Dex in wild-type peritoneal macrophages. Error bars
represent standard deviations.
(C) Recruitment of IRF3 to the proximal promoter regions of Scyb9 and Clic4, but not Nfkbia or Gro1, in response to LPS. Recruitment of
IRF3 was largely inhibited by Dex. Proximal regions of Scyb9, Clic4, Nfkbia, and Gro1 promoters that includes an NF-κB site were analyzed
by ChIP assays using the indicated antibodies. Crosslinking was performed 1 hr after treatment with LPS and Dex.
(D) Expression profiles of IP10, Clic4, and Nfkbia in response to LPS and Dex in control (WT) and MyD88−/− peritoneal macrophages. Gene
expression was determined by real-time quantitative PCR. Error bars represent standard deviations.
Cell
714Figure 6. GR and PPARγ Function in a Combinatorial Manner to Inhibit LPS Responses
(A) Combinatorial interactions between GR and PPARγ agonists at a genome-wide level. Peritoneal macrophages were stimulated with LPS
in the absence or presence of Dex alone, GW7845 alone, or the combination of Dex plus GW7845. The panel illustrates LPS-target genes
exhibiting a >40% reduction of the LPS response in the presence of at least one agonist. Effects of agonists on the LPS response are color
coded according to the legend in Figure 1C. Red arrows indicate genes in which one agonist abolished strong inhibitory effects of the other
agonist. Blue arrows indicate genes in which the combination of Dex and GW7845 resulted in stronger inhibition of the LPS response than
either agonist alone.
(B) Confirmation of combinatorial effect of GR and PPARγ agonists on regulation of LPS-target genes by Northern blotting. Macrophages
were treated with LPS for 6 hr in the presence of the indicated concentrations (10 nM, 1 M) of agonists.
(C) Confirmation of combinatorial effect of GR and LXR agonists on regulation of LPS-target genes by Northern blotting.
(D) Confirmation of combinatorial effect of GR and PPARγ agonists (1 M) on iNOS expression by real-time quantitative PCR. Error bars
represent standard deviations.
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715sequences did not correlate with signal- or gene-spe-
cific patterns of regulation. NF-κB binding sites were
identified in promoters of genes that were sensitive to
nuclear-receptor agonists following activation by LPS
or poly I:C (e.g., iNOS, Figure 2D), in promoters of
genes that were nuclear-receptor-sensitive following
LPS but not poly I:C activation (e.g., Clic4, Figure 5A
and data not shown), and in promoters of genes that
were nuclear receptor resistant regardless of the signal
(e.g., Nfkbia and Gro1, Figure 5A and data not shown).
In each case, transcriptional responses to LPS required
p65 (Figure S1). The recent finding that a subset of NF-
κB sites appear to determine the utilization of IRF3 as
a coactivator of p65 (Leung et al., 2004) suggested the
possibility that this might be a basis for gene-specific
sensitivity to repression by GR. To examine this, we
chose the Scyb9 and Clic4 genes because they were
highly IRF3 dependent, Dex sensitive NF-κB target
genes that did not contain ISRE motifs within their
proximal promoter or distal upstream regions (Figures
5A and 5B). The Nfkbia and Gro1 genes were chosen
for comparison because they were highly induced by
LPS in an IRF3-independent manner, were Dex resis-
tant, contained well-characterized κB elements, and
lacked proximal or distal ISRE elements (Figures 5A
and 5B). ChIP experiments revealed that p65 was re-
cruited to each of these genes in response to LPS, as
expected (Figure 5C). IRF3 was recruited to the proxi-
mal promoter regions of Scyb9 and Clic4 in response
to LPS, but not to the Nfkbia or Gro1 promoters, con-
sistent with the requirement of Scyb9 and Clic4 for IRF3
for activation and confirming a gene-specific recruit-
ment of IRF3 to a subset of p65 target genes. Signifi-
cantly, treatment with Dex had no effect on the recruit-
ment of p65 to any of these four target genes but
inhibited the recruitment of IRF3 to the Scyb9 and Clic4
promoters, coincident with ligand-dependent recruit-
ment of GR to these promoters (Figure 5C).
MyD88 Dictates GR Sensitivity of IRF3/7-Dependent
Gene Expression
Because TLR3 and TLR4 activate IRF3 and NF-κB
through the TRIF-dependent pathway, while TLR4, in
addition, activates NF-κB and MAP kinases via the
MyD88-dependent pathway, these observations raised
the possibility that glucocorticoid sensitivity was dic-
tated by the utilization of the MyD88-dependent path-
way. To initially test this hypothesis, we determined the
profile of dexamethasone-sensitive genes in macro-
phages treated with immunostimulatory DNA (CpG1668)
to activate TLR9, which exclusively couples to the
MyD88-dependent pathway (Hacker et al., 2000; Krug(E) Combinatorial interactions between GR and PPARγ at the promoter levels. RAW 264.7 cells were transfected with a luciferase reporter
plasmid under transcriptional control of the iNOS promoter, PPARγ, and RXRα expression plasmids. Cells were treated with the indicated
combinations of LPS, Dex, and GW7845 and analyzed for luciferase activity 24 hr later. Error bars represent standard deviations.
(F) In vivo effects of combinations of GR and PPARγ agonists on the response to intraperitoneal injection of LPS. Six C57BL6 mice were
pretreated with the indicated combinations of GW7845 (1 mg/kg) and Dex (1 mg/kg) for 7 days, injected intraperitoneally with LPS (1 mg) and
circulating levels of IL-12 p40 were measured by ELISA 8 hr later. Error bars represent standard deviations.
(G) In vivo effects of combinations of GR and LXR agonists on the response to intraperitoneal injection of LPS. Six C57BL6 mice were
pretreated with the indicated combinations of Dex (1 mg/kg) and T1317 (10 mg/kg) for 7 days, injected intraperitoneally with LPS (1 mg) and
circulating levels of TNFα were measured by ELISA 6 hr later. Error bars represent standard deviations.
combinations of Dex and GW3965 also demonstratedet al., 2004). As in the case of polyI:C-stimulated cells,
the overall profile of transcriptional activation induced
by CpG1668 was very similar to that induced by LPS.
Remarkably, 100% of the genes that were highly in-
duced by all three TLR agonists and were Dex resistant
when activated by polyI:C but Dex sensitive when acti-
vated by LPS, were also Dex sensitive when activated
by CpG1668 (Figure 3A). Furthermore, the quantitative
extent of Dex-mediated repression was more pro-
nounced following TLR9 stimulation than TLR4 stimula-
tion in nearly every case (Figure 3A). To determine
whether Dex sensitivity of the response to LPS requires
signaling through the MyD88 pathway, experiments
were performed in MyD88−/− macrophages (Adachi et
al., 1998). In these cells, LPS activation is entirely TRIF
dependent (Akira and Takeda, 2004; Kawai et al., 2001).
Remarkably, IRF3-dependent genes that were Dex
sensitive in wild-type cells became Dex resistant in
MyD88−/− cells, regardless of whether they contained
ISRE or κB elements (Figure 5D). These findings sug-
gest that signaling through the MyD88-dependent
pathway specifies Dex sensitivity of this set of genes.
GR, PPAR, and LXR Function in a Combinatorial
Manner to Inhibit LPS Responses
The observation that GR, PPARγ, and LXR agonists re-
pressed overlapping but distinct sets of LPS target
genes by p65-dependent and p65-independent mecha-
nisms raised the possibility that they might exert com-
binatorial effects on inflammatory responses. To test
this hypothesis, gene expression profiling experiments
were performed to characterize LPS responses in the
presence or absence of combinations of saturating
concentrations of GR, PPARγ, and LXR agonists. The
results of this analysis for the combination of Dex and
the PPARγ agonist GW7845 are illustrated in Figure 6A,
restricted to the subset of genes transrepressed by at
least one agonist. While several examples were ob-
served in which nuclear-receptor-specific inhibitory ef-
fects of one agonist were reversed by addition of the
second agonist (red arrows), the major impact of the
combination of agonists was to increase the strength of
inhibition of a subset of LPS target genes (blue arrows).
These results were confirmed by additional experi-
ments that examined the concentration dependence of
combinatorial interactions by Northern blot analysis
and quantitative PCR analysis of representative target
genes (Figures 6B and 6D). Low concentrations of Dex
and GW7845 (10 nM) that exerted relatively little repres-
sive effects when used individually could act synergisti-
cally in combination (Figure 6B). Parallel studies of
Cell
716Figure 7. Receptor-, Signal-, and Gene-Specific Counterregulation of Inflammatory Responses by GR, PPARγ, and LXRs
(A) Venn diagrams derived from the complete data set used to generate Figures 2B and 2C indicating sensitivity of LPS- and poly I:C-
responsive genes to GR, PPARγ, and LXR-specific agonists.
(B) Representative functional annotations corresponding to Biological Process terms derived from the Gene Ontology database that were
significantly enriched in the sets of LPS- and poly I:C-responsive genes. p represents the probability of obtaining the indicated number n
genes within the category by chance determined as previously described (Ogawa et al., 2004). Color-coding corresponds to the following p
values; light green, p less than 0.01; medium green, p less than 0.0001; dark green, p less than 106.
(C) Model for signal-specific GR-mediated transrepression, determined by utilization of p65 as an obligate TLR4-specific coactivator of IRF3.
IRF-mediated activation of ISRE-containing genes by TLR4 and TLR9 through MyD88-pathway requires that p65 function as a signal-specific
coactivator. The p65/IRF interaction is disrupted by liganded GR, resulting in transrepression. TLR3-specific activation of IRF3 through the
TRIF pathway is p65 independent and hence GR resistant.
(D) Model for gene-specific GR-mediated transrepression, determined by utilization of IRF3 as an obligate promoter-specific coactivator of
NF-κB. The IRF3/p65 interaction is disrupted by liganded GR, providing an explanation for promoter-specific inhibition of the LPS response.
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717additive or synergistic effects on LPS target genes (Fig-
ure 6C and data not shown).
To determine whether combinatorial effects of GR,
PPARγ, and LXR agonists acted at the promoter level,
iNOS promoter activity was evaluated in RAW264.7
cells. The iNOS promoter was chosen for this analysis
because the endogenous iNOS gene was subject to
combinatorial inhibition by GR, PPARγ, and LXR ago-
nists, its transcriptional activation requires binding
sites for NF-κB (Lowenstein et al., 1993), and maximum
responses to LPS required IRF3 (data not shown). As
shown in Figure 6E, GR and PPARγ agonists inhibited
iNOS promoter activity in a dose-dependent manner.
When cells were treated with the combination of Dex
and GW7845, at least additive effects with respect to
inhibition of LPS response were observed at both satu-
rating and nonsaturating concentrations of ligands (Fig-
ure 6E). Similar results were observed for the combina-
tion of GR and LXR agonists (data not shown).
Although GR-mediated repression did not require
NCoR (Figure 1B), we recently found that the ability of
PPARγ to repress LPS activation of the iNOS promoter
required NCoR (G.P. and C.K.G., unpublished data).
These findings indicate that at least two distinct recep-
tor-specific mechanisms are utilized by GR and PPARγ
to repress LPS activation of the iNOS promoter, provid-
ing a potential explanation for synergistic repression
when GR and PPARγ agonists are used in combination.
To investigate whether combinatorial interactions be-
tween PPARγ agonists and Dex observed in primary
macrophages would also occur in an in vivo model sys-
tem, we evaluated the IL-12 p40 subunit, as this was
synergistically repressed in primary macrophages by
GW7845 and Dex, but not by the combination of Dex
and T1317. Consistent with these findings, treatment of
mice with the combination of GW7845 and Dex prior to
injection with LPS resulted in significantly greater inhi-
bition of circulating IL-12 p40 than either agonist alone
(Figure 6F). For the combination of GR and LXR ago-
nists, we evaluated TNFα, based on synergistic inhibi-
tion by Dex and T1317 in primary macrophages. Treat-
ment of mice with the combination of Dex and T1317
resulted in significantly greater inhibition of circulating
tumor necrosis factor α (TNFα) levels following injection
with LPS than observed following either agonist alone
(Figure 6G).
Biological Functions Associated with Nuclear-
Receptor-Sensitive and Nuclear-Receptor-
Resistant TLR Target Genes
The identification of distinct subsets of TLR3 and TLR4
target genes exhibiting nuclear-receptor-sensitive or
nuclear-receptor-resistant profiles raises the question
of whether these genes participate in distinct biological
processes. Venn diagrams illustrating the overlapping
and distinct subsets of genes subject to transrepres-
sion by GR, PPAR, and LXR following macrophage acti-
vation by LPS and poly I:C are illustrated in Figure 7A.
To investigate the potential meaning of these findings
at a biological level, statistical analysis of the functional
annotations associated with specific sets of differenti-
ally regulated genes was performed using annotations
provided by the Gene Ontology (GO) database (GeneOntology Consortium, 2001). A subset of this analysis
is presented in Figure 7B, illustrating major categories
including immune cell homeostasis, response to virus,
cytokine, chemokine signaling, etc. The results of this
analysis suggest significant functional differences in the
sets of nuclear-receptor-sensitive and nuclear-receptor-
resistant LPS-target genes. For example, the set of
genes that was activated by LPS and resistant to GR,
PPARγ, and LXR agonists was enriched for functional
annotations linked to metabolism (Figure 7B). In addi-
tion, transcriptional activation of the core components
of the NF-κB pathway by LPS or poly I:C was almost
completely resistant to repression by all three nuclear-
receptor agonists (Figure S3B). We also placed data for
GR-mediated repression of LPS- and poly I:C-inducible
genes on KEGG pathway maps (Kanehisa, 1996) and
provide an example for the TLR signaling pathway in
Figure S4. This figure indicates that components of the
TLR signaling pathway in addition to NF-κB factors are
Dex resistant, while TLR-activated chemokines and
cytokines exhibit differential patterns of sensitivity that
relate to proinflammatory effects and chemotaxis.
GR, PPARγ, and LXR regulated functionally overlap-
ping sets of genes, but also targeted genes in function-
ally related groups in a nuclear-receptor-specific man-
ner. For example, the list of repressed genes with
functional annotations linked to hemopoiesis by the
Gene Ontology Consortium reached statistical signifi-
cance for Dex, but not LXR or PPARγ agonists (Figure
7B). Repressive actions of each nuclear-receptor ligand
on specific genes involved in immune cell migration,
differentiation, and activation are illustrated in Figure
S3B. Overall, Dex inhibited a larger number of genes
involved in immune cell activation to a greater extent
than LXR or PPARγ agonists, which may explain in part
why LXR and PPARγ agonists are not as effective as
Dex in acute models of inflammation. Significant differ-
ences in effects of the three receptor-specific agonists
on chemokine gene expression were observed, sug-
gesting that each receptor may play a context-specific
role in regulating recruitment of specific immune cells
to sites of inflammation.
Discussion
Signal-Specific, Gene-Specific, and Nuclear-
Receptor-Specific Transrepression
The present studies have used a combination of gene
expression profiling and molecular analysis to investigate
nuclear-receptor-specific and combinatorial mechanisms
of transrepression by nuclear receptors. These obser-
vations extend the spectrum of nuclear-receptor- and
promoter-specific inhibition of signal-dependent gene
expression, demonstrating that GR, PPARγ, and LXR
repress overlapping but distinct subsets of inflamma-
tory response genes, consistent with the large number
of mechanisms that have been proposed for negative
regulation by nuclear receptors (De Bosscher et al.,
2003). The observation that a significant set of genes
that were sensitive to nuclear-receptor-dependent re-
pression when activated through TLR4 became resis-
tant to repression when activated through TLR3 also
indicates that transrepression programs mediated by
Cell
718GR, PPARγ, and LXRs are regulated in a signal-specific
manner. Of the 262 genes scored as being LPS induc-
ible and Dex sensitive in these studies, at least 85
genes fit with the hypothesis that disruption of IRF3/
p65 complexes is a quantitatively important component
of the transrepression mechanism. Taken together with
the results of studies in MyD88−/− macrophages (Figure
5D) and the patterns of gene expression following TLR9
activation (Figure 3A), these findings support a unifying
model in which TLR signaling through MyD88 specifies
glucocorticoid sensitivity of IRF-dependent genes
through the utilization of IRF/p65 complexes (Figure
7C). As IRF7 is involved in TLR9-MyD88-dependent
gene activation (Kawai et al., 2004), these results imply
that the mechanism of GR-mediated repression oper-
ates through both IRF3 and IRF7. These findings thus
reveal a mechanism of signal-specific transrepression
that is utilized by a large group of functionally interre-
lated genes. Distinct regions of GR appear to be in-
volved in mediating repression of AP-1 target genes
(Bladh et al., 2005) and it will be of interest to explore
signal-specific modulation of transrepression in re-
sponse to other proinflammatory cytokines that induce
AP-1 and STAT transcription factors, such as TNFα
and IFNβ.
Conversely, the ability of IRF3 to function as an
essential coactivator of p65 on a subset of NF-κB tar-
get genes provides an explanation for how transrepres-
sion by GR can be achieved in a gene-specific manner
(Figure 7D). NF-κB target genes that are resistant to
GR-mediated transrepression are predicted to utilize
other classes of coactivators, such as Bcl3 (Leung et
al., 2004), that may prevent the interaction of GR with
DNA bound NF-κB. Consistent with this, ChIP experi-
ments demonstrated recruitment of GR to the Dex-sen-
sitive Scyb9 and Clic4 promoters. A significant number
of Dex-sensitive NF-κB target genes are not IRF3-depen-
dent, indicating a requirement for additional mecha-
nisms. Virtually all of the Dex-sensitive poly I:C-induc-
ible genes were also Dex sensitive when activated by
LPS and CpG1668 (Figure S3A), suggesting the utiliza-
tion of common, signal-independent transrepression
mechanisms for this class of genes that remain to be
defined.
Physiological Implications for Cellular Responses
to Bacterial and Viral Pathogens
The observation that TLR-responsive genes exhibit dif-
ferent sensitivities to repression by nuclear receptors
suggests that they play distinct biological roles in de-
termining cellular responses to infection and other in-
flammatory processes. By specifically targeting p65/
IRF3 complexes, GR is able to discriminate signals initi-
ated by TLRs that either do or do not couple to the
MyD88 signaling pathway, providing a biological ratio-
nale for the context-specific utilization of these com-
plexes. The prediction arising from these studies that
the antiviral program mediated by TLR3 should be re-
sistant to GR-mediated repression while the antiviral
program elicited by activation of TLR9 should be GR
sensitive is consistent with clinical experience. Innate
immune responses to herpes simplex virus infections
involve TLR9 (Krug et al., 2004; Lund et al., 2003), and
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Eteroid use is generally contraindicated in the setting
f HSV infections because this may exacerbate the se-
erity of infection.
In addition to defining combinatorial control of in-
lammatory responses at the promoter level, these
tudies also suggest a higher level of regulation that
erves to integrate both local and systemic signaling
athways. In the case of GR, the endogenous cortico-
teroid ligands are produced in the adrenal cortex un-
er the control of the hypothalamic-pituitary-adrenal
xis. Circulating corticosteroids diffuse into cells and
ind to GR in virtually all tissues with subnanomolar
ffinities, providing coordinate regulation of gene ex-
ression at the whole-body level. In contrast, PPARγ
nd LXRs are activated by metabolites of fatty acids
nd cholesterol, respectively, that are produced locally
ithin the cell and bind with relatively low affinity. In
ddition, the expression of PPARγ and LXRα and the
roduction of regulatory ligands are determined by lo-
al cytokines and other regulatory systems (Ricote et
l., 2004). Taken together, these observations suggest
model in which GR and PPARγ/LXR integrate sys-
emic and local regulatory signals so as to coordinate
ranscriptional responses to infection throughout the
ody.
linical Implications
uclear receptors are important targets of drugs used
n a variety of human disease settings. In many cases,
he ability to achieve desirable therapeutic effects with
natural or synthetic nuclear-receptor agonist is lim-
ted by undesirable or unacceptable side effects. For
xample, glucocorticoids are potent anti-inflammatory
rugs but can cause or exacerbate hypertension, dia-
etes, obesity, and dyslipidemia. Emerging information
n the ability of selective modulators of nuclear re-
eptors to alter the specificity of coactivator and core-
ressor recruitment raises new possibilities for the de-
elopment of novel pharmaceutical agents (Smith and
’Malley, 2004). The present studies suggest an alter-
ative and potentially complementary strategy to lever-
ge desirable therapeutic effects while minimizing side
ffects. Using chronic, steroid-dependent inflammatory
iseases as an example, it is possible that anti-inflam-
atory actions of synthetic glucocorticoids could be
chieved at lower doses with fewer side effects by sim-
ltaneous administration of PPARγ or LXR agonists.
urther investigation of these combinatorial mecha-
isms may provide new insights into how nuclear re-
eptors control signal-activated transcription and lead
o novel strategies for treatment of inflammatory dis-
ases.
xperimental Procedures
ell Culture
hioglycollate-elicited macrophages were isolated by peritoneal la-
age 3 days following peritoneal injection of 2.5 ml 3% thioglycol-
ate (DIFCO). Cells were plated in RPMI medium 1640 and 10% fetal
ovine serum and washed; after 5 hr the medium was removed
nd cells were fed with fresh medium containing 0.5% fetal bovine
erum. LPS (Sigma) was used at a concentration of 100 ng/ml.
uclear-receptor ligands were used at 1 M concentrations except
s indicated. Fetal liver-derived macrophages generated from
14.5 embryo liver were plated and cultured in RPMI with 10% fetal
Crosstalk between Nuclear Receptors and TLRs
719bovine serum plus L cell media for 7 days as described (Ogawa et
al., 2004). Fetal liver-derived macrophages of TNF−/−cRel−/− (con-
trol) and TNF−/−cRel−/−RelA−/− (NF-κB−/−) were obtained by mating
TNF−/−cRel−/−RelA+/− mice and by genotyping the embryos.
Expression Array Profiling
Cells were lysed with Trizol (Invitrogen) and total RNA was purified
using RNeasy columns (Qiagen). cRNA was generated from 10 g
total RNA using Superscript (Invitrogen) and the High Yield RNA
transcription labeling kit (Enzo). Fragmented cRNA was hybridized
to Affymetrix Mu11 or Codelink mouse Uniset 1 microarrays ac-
cording to the manufacturer’s instructions. Data were analyzed with
Microarray Suite (Affymetrix), GeneSpring (Silicongenetics) and in-
house software developed as described (Ogawa et al., 2004). Two
to four biological replicates were performed for each experimental
condition. In addition, results for NR transrepression of LPS signal-
ing were independently validated on both microarray platforms.
Computational Analysis
Proximal promoter regions were extracted for each gene repre-
sented on the microarray using the May 2004 mouse genome as-
sembly with the method as described (Halees et al., 2003). Analysis
was restricted to the region 1 kb upstream of the transcription start
site. In cases were several possible alternative promoters may be
present, analysis was focused on the most 5# transcription start
site. Motif discovery was performed using a comparative algorithm
previously described (Segal et al., 2002). Promoters were initially
divided into two sets: those that were upregulated by LPS and
those that were present on the array but did not change in re-
sponse to LPS. An exhaustive search for all n-mers (6 < n < 12)
was performed and each n-mer was scored for its enrichment in
the promoters upregulated by LPS using the hypergeometric distri-
bution. The top 500 n-mers with a p value less than 0.01 were then
clustered together and used to create position-specific probability
matrices. The matrices were then further optimized to discriminate
between the LPS responsive and nonresponsive genes by the
methods as described (Segal et al., 2002).
Transient Transfection and Reporter Studies
Transient transfections were performed as described (Ricote et al.,
1998). RAW 264.7 cells were transfected with iNOS promoter lucif-
erase, pCMX-PPARγ and renilla luciferase reporter plasmid was
also cotransfected as an internal control (Promega). Cells were
treated with LPS in the presence of GR, PPAR, and LXR agonists
and harvested 24 hr later for analysis of luciferase activity. Double-
stranded, short interfering RNAs (siRNA) were synthesized by Dhar-
macon Research (Lafayette) and were transfected for 48 hr prior to
activation with ligands and LPS induction as previously described
(Perissi et al., 2004). Data are represented as mean ±SD.
GST Pull-Down Assays
GST pull-down assays were carried out as described previously (Li
et al., 2000). GST fusion proteins were produced as crude bacterial
lysates and immobilized on glutathione agarose beads. p65, IRF3,
full-length GR, GR(K471A), and GR-DBD proteins were translated
in vitro using 35S-labeled methionine and TnT-coupled reticulocyte
lysate system (Promega).
ChIP Assay
ChIP assay was conducted as previously (Ogawa et al., 2004; Per-
issi et al., 2004). Anti-IRF3 (Zymed), anti-CBP (Santa Cruz), anti-
p65 (Santa Cruz), and anti-GR (Santa Cruz) antibodies were used
in immunoprecipitation experiments.
RNA Analysis
RNA analysis by Northern blotting was performed as described
(Valledor et al., 2004). Real-time quantitative PCR (SYBRgreen)
analysis was performed on an Applied Biosystems 7300 Real-Time
PCR system.
LPS-Induced Endotoxin Shock and In Vivo Studies
Combinatorial effects of GR, PPARγ, and LXR agonists in antago-
nism of LPS responses in vivo were evaluated by measuring TNFαand IL-12 p40 levels 6 and 8 hr after intraperitoneal injection of LPS
at 1 mg/mouse, respectively. Mice were orally dosed daily with Dex
for 7 days and were intraperitoneally injected with LPS (1 mg/
mouse). Blood was collected after LPS stimulation and analyzed
for cytokine levels by ELISA. At a minimum, six mice were used for
each experimental condition.
Supplemental Data
Supplemental Data include four figures and one table and can be
found with this article online at http://www.cell.com/cgi/content/
full/122/5/707/DC1/.
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